Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/43104
Title: Anti-inflammatory effect of alcoholic extract of Entada pursaetha DC in LPS-induced inflammation in mice and RAW264.7 cells
Authors: Kumari, Rashmi Rekha
Lingaraju, Madhu Cholenahalli
Gupta, Gaurav
More, Amar Sunil
Balaganur, Venkanna
Kumar, Dhirendra
Kumar, Pankaj
Kumar, Dinesh
Sharma, Anil Kuma
Mishra, Santosh Kumar
Tandan, Surendra Kumar
Keywords: Anti-inflammatory activity;Cytokines;Entada pursaetha;Lipopolysaccharide;RAW 264.7 cells
Issue Date: Jun-2017
Publisher: NISCAIR-CSIR, India
Abstract: Entada pursaetha (Fabaceae) is an active, oriental herbal medicine used to treat various inflammatory diseases. Limited information on the use of stem in ethno medicine in painful conditions of joints prompted us to verify its usage for in vitro and in vivo anti-inflammatory action. The present study was designed to evaluate the anti-inflammatory effects of ethanolic extract of E. pursaetha (EPE) on the production of inflammatory mediators in macrophages and LPS (lipopolysaccharide)-induced systemic inflammation. EPE was studied for its anti-inflammatory activity in on the production of inflammatory mediators in systemic inflammation triggered by LPS and LPS-stimulated RAW 264.7 cells. Plasma tumor necrosis factor alpha (TNF-α), interleukin 1 beta (IL-1β) proteins and total nitrate and nitrite levels were significantly increased in vehicle-treated control group of mice challenged with LPS (4 mg/kg b.wt.). Pre treatment of EPE at 300 mg/kg b.wt. Continuously for 3-days prior to LPS challenge significantly reduced these cytokine levels and nitrate plus nitrite levels in plasma. EPE treatment also significantly inhibited the LPS-induced production of NO (nitric oxide), IL-1β and TNF-α in RAW 264.7 cell. This study demonstrates the anti-inflammatory effects of EPE in both in vivo and in vitro model of inflammation potentially justifying the usage of Entada pursaetha plant as traditional herbal medicine for the treatment of inflammatory diseases.
Page(s): 140-149
ISSN: 0975-0959 (Online); 0301-1208 (Print)
Appears in Collections:IJBB Vol.54(3&4) [June-August 2017]

Files in This Item:
File Description SizeFormat 
IJBB 54(3&4) 140-149.pdf763.19 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.